Pylotrip
- Targeting H. pylori: Specifically formulated to eradicate H. pylori in active chronic gastric, duodenal, and gastric ulcers.
- Triple Action Pharmacology: Combines the proton-pump inhibiting power of lansoprazole with the antibacterial effects of amoxicillin and clarithromycin.
- Recommended Dosage: Advised adult dosage of one strip twice daily for 7-14 days, as directed by healthcare professionals.
- Comprehensive Gastrointestinal Care: Provides a holistic approach to gastrointestinal health with a focus on effective eradication and symptom management.
Voniza 10
- Introducing Voniza: A powerful solution for gastric ulcers, reflux esophagitis, and ulcer prevention during aspirin or NSAID therapy.
- Potassium competitive acid blocker: Voniza effectively inhibits stomach acid production, offering relief and protection.
- Flexible dosing options: Tailored treatment plans ensure optimal results for each patient's needs.
- Convenient administration: Voniza's ease of use enhances patient compliance and treatment efficacy.
Voniza 20
- Introducing Voniza: A powerful solution for gastric ulcers, reflux esophagitis, and ulcer prevention during aspirin or NSAID therapy.
- Potassium competitive acid blocker: Voniza effectively inhibits stomach acid production, offering relief and protection.
- Flexible dosing options: Tailored treatment plans ensure optimal results for each patient's needs.
- Convenient administration: Voniza's ease of use enhances patient compliance and treatment efficacy.
Vonocab 10
- Vonocab is a potent potassium-competitive acid blocker (P-CAB) that effectively treats gastric ulcers, duodenal ulcers, and reflux esophagitis.
- It helps prevent the recurrence of ulcers during low-dose aspirin or NSAID use and assists in the eradication of Helicobacter pylori.
- Vonocab operates by inhibiting H+, K+-ATPase, providing long-lasting acid suppression and relief from upper gastrointestinal tract conditions.
Vonocab 20
- Vonocab is a potent potassium-competitive acid blocker (P-CAB) that effectively treats gastric ulcers, duodenal ulcers, and reflux esophagitis.
- It helps prevent the recurrence of ulcers during low-dose aspirin or NSAID use and assists in the eradication of Helicobacter pylori.
- Vonocab operates by inhibiting H+, K+-ATPase, providing long-lasting acid suppression and relief from upper gastrointestinal tract conditions.
Xenole 375
- Relieves symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis
- Reduces the risk of NSAID-associated gastric ulcers
- Unique formulation includes an immediate-release Esomeprazole layer and an enteric-coated Naproxen core
- Carefully considered dosage and administration guidelines aim to alleviate discomfort and improve patient well-being
Xenole 500
- Relieves symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis
- Reduces the risk of NSAID-associated gastric ulcers
- Unique formulation includes an immediate-release Esomeprazole layer and an enteric-coated Naproxen core
- Carefully considered dosage and administration guidelines aim to alleviate discomfort and improve patient well-being